3-(4-CHLORO-3,5-DIMETHYL-PYRAZOL-1-YLMETHYL)-4-METHOXY-BENZOIC ACID
|
- $252 - $405
- Product name: 3-(4-CHLORO-3,5-DIMETHYL-PYRAZOL-1-YLMETHYL)-4-METHOXY-BENZOIC ACID
- CAS: 956204-52-7
- MF: C14H15ClN2O3
- MW: 294.73
- EINECS:
- MDL Number:MFCD05256464
- Synonyms:ART-CHEM-BB B028534;AKOS B028534;AKOS PAO-0106;3-[(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]-4-METHOXYBENZOIC ACID;3-(4-CHLORO-3,5-DIMETHYL-PYRAZOL-1-YLMETHYL)-4-METHOXY-BENZOIC ACID;Benzoic acid, 3-[(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl]-4-methoxy-
3 prices
Selected condition：
Brand
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- ManufacturerCrysdot
- Product numberCD11003770
- Product description3-((4-Chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl)-4-methoxybenzoicacid 95+%
- Packaging1g
- Price$405
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11003770
- Product description3-((4-Chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl)-4-methoxybenzoic acid 95+%
- Packaging1g
- Price$405
- Updated2026-05-26
- Buy
- ManufacturerMatrix Scientific
- Product number036462
- Product description3-[(4-Chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl]-4-methoxybenzoic acid
- Packaging500mg
- Price$252
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Crysdot | CD11003770 | 3-((4-Chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl)-4-methoxybenzoicacid 95+% | 1g | $405 | 2021-12-16 | Buy |
| Crysdot | CD11003770 | 3-((4-Chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl)-4-methoxybenzoic acid 95+% | 1g | $405 | 2026-05-26 | Buy |
| Matrix Scientific | 036462 | 3-[(4-Chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl]-4-methoxybenzoic acid | 500mg | $252 | 2021-12-16 | Buy |
Properties
Boiling point :471.0±45.0 °C(Predicted)
Density :1.31±0.1 g/cm3(Predicted)
pka :4.39±0.10(Predicted)
Density :1.31±0.1 g/cm3(Predicted)
pka :4.39±0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|